Cargando…

TARGETING CANCER STEM CELLS WITH A CDK2 INHIBITOR IN GLIOBLASTOMA

Glioblastoma (GB) is the most common and aggressive adult brain tumor with no cure. Brain tumor stem cells (BTSCs) are a rare population of self-renewing multipotent stem cells in GB that contribute to tumorigenesis, therapeutic resistance, and tumour recurrence. Here, we report a CDK2 inhibitor tha...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mahmnoudian, Elham, Qu, Dianbo, Lotfipour, Farzaneh, Jahani-Asl, Arezu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2023
Materias:	Posters
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10337562/ http://dx.doi.org/10.1093/noajnl/vdad071.049

Ejemplares similares

REPURPOSING OF FDA APPROVED COMPOUNDS TO INHIBIT OSM/OSMR SIGNALING IN GLIOBLASTOMA
por: Lotfipour, Farzaneh, et al.
Publicado: (2023)

DETERMINING THE ROLE OF GALECTIN1/HOXA5 INTERACTION AND REGULATION IN GLIOBLASTOMA DEVELOPMENT
por: Qu, Dianbo, et al.
Publicado: (2023)

DDRE-21. THE FUNCTION OF MITOCHONDRIAL OSMR IN GLIOMA STEM CELL RESPIRATION AND GLIOBLASTOMA PATHOGENESIS
por: Jahani-Asl, Arezu, et al.
Publicado: (2021)

Targeting OSMR in glioma stem cells
por: Mohan, Sushmetha, et al.
Publicado: (2017)

OSMR INTERACTOME MAPPING REVEALS THE SIGNIFICANCE OF A CHLORIDE CHANNEL IN CYTOKINE REGULATION AND BRAIN TUMOUR STEM CELL SELF-RENEWAL
por: Randhawa, Kamaldeep, et al.
Publicado: (2023)

Regulation of neural stem cell fate decisions by mitochondrial dynamics
por: Laaper, Matthew, et al.
Publicado: (2018)

OSMR controls glioma stem cell respiration and confers resistance of glioblastoma to ionizing radiation
por: Sharanek, Ahmad, et al.
Publicado: (2020)

In situ detection of protein-protein interaction by proximity ligation assay in patient derived brain tumor stem cells
por: Sharanek, Ahmad, et al.
Publicado: (2022)

P1412: UNCOUPLING INK4 PROTEINS FROM CDK4/CDK6 IN HEMATOPOIETIC STEM CELLS
por: Schirripa, A., et al.
Publicado: (2022)

Targeting CDK9 for the Treatment of Glioblastoma
por: Ranjan, Alice, et al.
Publicado: (2021)

Revisiting CDK Inhibitors for Treatment of Glioblastoma Multiforme
por: Lubanska, Dorota, et al.
Publicado: (2017)

Cdk4 Regulates Glioblastoma Cell Invasion and Stemness and Is Target of a Notch Inhibitor Plus Resveratrol Combined Treatment
por: Giordano, Francesca, et al.
Publicado: (2023)

Chemoresistance in human ovarian cancer: the role of apoptotic regulators
por: Fraser, Michael, et al.
Publicado: (2003)

P1269: VIP152 IS A NOVEL CDK9 INHIBITOR WITH IMPROVED SELECTIVITY, TARGET MODULATION, AND CARDIAC SAFETY IN PATIENTS WITH LYMPHOMA
por: Frigault, M., et al.
Publicado: (2022)

P1407: CDK6 IN HEMATOPOIETIC STEM CELLS: MORE THAN A CELL CYCLE KINASE
por: Mayer, I., et al.
Publicado: (2022)

Co-targeting CDK2 and CDK4/6 overcomes resistance to aromatase and CDK4/6 inhibitors in ER+ breast cancer
por: Al-Qasem, Abeer J., et al.
Publicado: (2022)

Myc targeted CDK18 promotes ATR and homologous recombination to mediate PARP inhibitor resistance in glioblastoma
por: Ning, Jian-Fang, et al.
Publicado: (2019)

Targeting Cell Cycle in Breast Cancer: CDK4/6 Inhibitors
por: Piezzo, Michela, et al.
Publicado: (2020)

UPAR AS A NOVEL IMMUNOTHERAPEUTIC TARGET IN RECURRENT GLIOBLASTOMA
por: Maich, William, et al.
Publicado: (2023)

An oncogenic splice variant of PDGFRα in adult glioblastoma as a therapeutic target for selective CDK4/6 inhibitors
por: Hamada, Taiji, et al.
Publicado: (2022)

Interrogating the interactions between myeloid derived suppressor cells and cancer stem cells in glioblastoma
por: Otvos, Balint, et al.
Publicado: (2013)

Identification of Quinazolinone Analogs Targeting CDK5 Kinase Activity and Glioblastoma Cell Proliferation
por: Peyressatre, Marion, et al.
Publicado: (2020)

Allostery governs Cdk2 activation and differential recognition of CDK inhibitors
por: Majumdar, Abir, et al.
Publicado: (2021)

Myf6/MRF4 is a myogenic niche regulator required for the maintenance of the muscle stem cell pool
por: Lazure, Felicia, et al.
Publicado: (2020)

Targeting transcription regulation in cancer with a covalent CDK7 inhibitor
por: Kwiatkowski, Nicholas, et al.
Publicado: (2014)

Targeting Aggressive Cancer Stem Cells in Glioblastoma
por: Seymour, Tracy, et al.
Publicado: (2015)

Transcriptional reprogramming of skeletal muscle stem cells by the niche environment
por: Lazure, Felicia, et al.
Publicado: (2023)

Targeting cancer stem cell propagation with palbociclib, a CDK4/6 inhibitor: Telomerase drives tumor cell heterogeneity
por: Bonuccelli, Gloria, et al.
Publicado: (2016)

DYRK1A Negatively Regulates CDK5-SOX2 Pathway and Self-Renewal of Glioblastoma Stem Cells
por: Chen, Brianna, et al.
Publicado: (2021)

CDK4/6 Inhibitor PD0332991 in Glioblastoma Treatment: Does It Have a Future?
por: Schröder, Lisette B. W., et al.
Publicado: (2015)

Development of CDK inhibitors as cancer therapeutics
por: Lane, D
Publicado: (2005)

Antioxidants cause rapid expansion of human adipose-derived mesenchymal stem cells via CDK and CDK inhibitor regulation
por: Sun, Li-Yi, et al.
Publicado: (2013)

The CDK inhibitor AT7519 inhibits human glioblastoma cell growth by inducing apoptosis, pyroptosis and cell cycle arrest
por: Zhao, Wenpeng, et al.
Publicado: (2023)

Multiple CDK inhibitor dinaciclib suppresses neuroblastoma growth via inhibiting CDK2 and CDK9 activity
por: Chen, Zhenghu, et al.
Publicado: (2016)

Targeting cyclin-dependent kinase 1 (CDK1) in cancer: molecular docking and dynamic simulations of potential CDK1 inhibitors
por: Sofi, Shazia, et al.
Publicado: (2022)

Osteogenic Differentiation of Mesenchymal Stem Cells via Curcumin-Containing Nanoscaffolds
por: Khezri, Khadijeh, et al.
Publicado: (2021)

Clinical development of IL13Rα2-targeting CAR T cells for the treatment of glioblastoma
por: Brown, Christine E, et al.
Publicado: (2015)

EXPLORING THE INTERPLAY BETWEEN BRAIN TUMOUR INITIATING CELLS AND THE TUMOUR MICROENVIRONMENT: POTENTIAL TARGETING STRATEGIES FOR GLIOBLASTOMA
por: Lubanska, Dorota, et al.
Publicado: (2023)

Bortezomib sensitizes human glioblastoma stem cells to adoptive natural killer cell cytotoxicity
por: Grossenbacher, Steven, et al.
Publicado: (2015)

Glioblastoma Stem Cells as a New Therapeutic Target for Glioblastoma
por: Kalkan, Rasime
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_7jl627aucp19nvqv1vp5lmqueh